Company Description
Nava is a vertically integrated, tech-enabled integrative healthcare practice combining traditional, functional, holistic, and regenerative medicine.
Our innovative medical practice uses a data-driven, personalized approach to optimize health and increase longevity.
We provide each client with an individualized wellness roadmap tailored to their specific symptoms, medical needs, and personal goals, which we refer to as their “Custom Vitality Plan” or “CVP”.
The client’s CVP is developed as part of our proprietary diagnostic process, the “Nava Method”, which utilizes propriety software owned and developed by Nava.
We believe that by offering innovative approaches that do not only treat the symptoms but that focus on the root causes of illness, we can not only treat chronic disease but help to prevent disease progression, increase longevity and improve quality of life.
We deliver our health services through three physical locations in the Baltimore/Washington Metro region.
We currently plan to open up to eight additional locations by the end of 2023, subject to market conditions and anticipated demand for our services.
Our on-premises locations offer a premium client experience and luxurious, spa-like atmosphere. There we provide hands-on treatment options including, but not limited to, physician appointments and medical procedures, intravenous micronutrient therapies, massage, acupuncture, and our aesthetic services.
| Country | United States |
| Founded | 2014 |
| Industry | Health Care |
| Sector | Health Care Providers & Services |
| Employees | 70 |
| CEO | Bernaldo Dancel |
Contact Details
Address: 9755 Patuxent Woods Drive, Suite 100 Columbia, MD 21046 United States | |
| Phone | (410) 910-6156 |
| Website | navacenter.com |
Stock Details
| Ticker Symbol | NAVA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.00 |
| CIK Code | 0001932231 |
| Employer ID | 32-0416441 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Bernaldo Dancel | Chief Executive Officer, President and Director Nominee |
| Dr. Douglas Lord | Chief Medical Officer and Director Nominee |
| Chien-Chien Jacques | Chief Financial Officer, Treasurer and Secretary |
| Hyun Soo Park | Chief Information Officer |
| Suzanne Coblentz | Chief Marketing Officer |
| Zachary Dancel | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 6, 2024 | D | Notice of Exempt Offering of Securities |
| Aug 30, 2024 | D | Notice of Exempt Offering of Securities |
| May 12, 2023 | 15-15D | Filing |
| Mar 24, 2023 | RW | Filing |
| Feb 14, 2023 | EFFECT | Notice of Effectiveness |
| Feb 14, 2023 | 8-A12B | Registration of securities |
| Feb 14, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 13, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 7, 2023 | FWP | Free Writing Prospectus |
| Feb 7, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |